share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:拟议出售证券
SEC announcement ·  03/14 10:39
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 03/14/2024, with an aggregate market value of $4,563.20. The shares were originally acquired on 10/07/2022 as part of a restricted stock vesting agreement with the issuer, serving as compensation for Austin. This upcoming sale follows a series of transactions over the past three months, where a total of 242,048 shares were sold for gross proceeds of approximately $340,176.64. The notice of the planned sale was filed on the same day as the sale, 03/14/2024, with the plan for this transaction having been adopted a year prior on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 03/14/2024, with an aggregate market value of $4,563.20. The shares were originally acquired on 10/07/2022 as part of a restricted stock vesting agreement with the issuer, serving as compensation for Austin. This upcoming sale follows a series of transactions over the past three months, where a total of 242,048 shares were sold for gross proceeds of approximately $340,176.64. The notice of the planned sale was filed on the same day as the sale, 03/14/2024, with the plan for this transaction having been adopted a year prior on 03/14/2023.
Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年3月14日出售3,968股A类股票,总市值为4563.20美元。这些股票最初是在2022年7月10日收购的,是与发行人签订的限制性股票归属协议的一部分,作为对奥斯汀的补偿。此次即将进行的出售是在过去三个月进行的一系列交易之后进行的,共出售了242,048股股票,总收益约为340,176.64美元。计划出售的通知是在2024年3月14日与出售的同一天提交的,该交易的计划是在一年前的2023年3月14日通过的。
Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年3月14日出售3,968股A类股票,总市值为4563.20美元。这些股票最初是在2022年7月10日收购的,是与发行人签订的限制性股票归属协议的一部分,作为对奥斯汀的补偿。此次即将进行的出售是在过去三个月进行的一系列交易之后进行的,共出售了242,048股股票,总收益约为340,176.64美元。计划出售的通知是在2024年3月14日与出售的同一天提交的,该交易的计划是在一年前的2023年3月14日通过的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息